Detalhe da pesquisa
1.
Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial.
Haematologica
; 104(11): 2274-2282, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30923094
2.
Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods.
Clin Chem Lab Med
; 56(2): 312-322, 2018 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28771430
3.
Analytical validation of the Hevylite assays for M-protein quantification.
Clin Chem Lab Med
; 56(7): 1169-1175, 2018 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29397379
4.
Predictors for successful PBSC collection on the fourth day of G-CSF-induced mobilization in allogeneic stem cell donors.
J Clin Apher
; 32(6): 397-404, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28139098
5.
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity.
Cancer Immunol Immunother
; 65(3): 327-39, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26861670
6.
Interference of daratumumab in monitoring multiple myeloma patients using serum immunofixation electrophoresis can be abrogated using the daratumumab IFE reflex assay (DIRA).
Clin Chem Lab Med
; 54(6): 1105-9, 2016 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26812873
7.
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.
Blood
; 120(13): 2700-3, 2012 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22879539
8.
Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial.
Haematologica
; 99(1): 148-54, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23996482
9.
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial.
Nat Commun
; 15(1): 1632, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38395969
10.
High detection rate of clinically relevant genomic abnormalities in plasma cells enriched from patients with multiple myeloma.
Genes Chromosomes Cancer
; 51(11): 997-1006, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22833442
11.
Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma.
Hemasphere
; 7(11): e976, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37928625
12.
A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma.
Blood
; 115(6): 1113-20, 2010 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-19880501
13.
Pomalidomide in Patients With Relapsed and/or Refractory Multiple Myeloma: A Prospective Study Within the Nationwide Netherlands Cancer Registry.
Hemasphere
; 6(2): e683, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35106452
14.
Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma.
Hemasphere
; 6(10): e786, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36204691
15.
Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients.
Oncoimmunology
; 11(1): 2015113, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36524210
16.
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used.
Cancer Immunol Immunother
; 60(2): 249-60, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21069321
17.
Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma.
Ophthalmology
; 123(10): 2265-7, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27476772
18.
Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma.
Ann Hematol
; 88(12): 1161-8, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19763570
19.
Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma.
Haematologica
; 93(1): 124-7, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18166796
20.
Intestinal involvement in amyloidosis is a sequential process.
Neurogastroenterol Motil
; 30(12): e13469, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30230124